
CAS 1092804-88-0
:Formula:C24H33N3O4
InChI:InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)/i11D2,12D2,13D2,14D2
InChI key:XKLMZUWKNUAPSZ-FUEQIQQISA-N
SMILES:[2H]C1(C(N(C(C(N1CC(COC2=CC=CC=C2OC)O)([2H])[2H])([2H])[2H])CC(=O)NC3=C(C=CC=C3C)C)([2H])[2H])[2H]
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Ranolazine-d8
CAS:Ranolazine-d8 is an analog of Ranolazine, which is a potent inhibitor of kinases. It has shown to be effective in inhibiting the growth of cancer cells and inducing apoptosis. Ranolazine-d8 is excreted in the urine and can be used as a biomarker for kinase activity. This compound has been extensively studied in Chinese medicinal research and has shown promising results as an anticancer agent. In vitro studies have demonstrated that it inhibits protein kinase C activity, which is involved in tumor growth and progression. Ranolazine-d8 may offer new therapeutic options for cancer treatment through its ability to target kinases and induce apoptosis in cancer cells.Formula:C24H33N3O4Purity:Min. 95%Molecular weight:435.6 g/mol

